SEX-RELATED DIFFERENCES IN THE PHARMACOLOGICAL TREATMENT OF MAJOR DEPRESSION - ARE WOMEN AND MEN TREATED DIFFERENTLY?

4Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: In the last decade, sex-related medicine has become an increasingly important area of research as insights in this field can improve treatment strategies and recovery. The aim of this study was to investigate sex-related differences in the prescription and kinds of psychopharmacological treatment in individuals with unipolar affective disorder. Subjects and methods: Data collected on 388 patients attending a psychiatric rehabilitation clinic (194 females, 194 males, mean age 52.3 years, standard deviation 7.8 years), who were matched by age and severity of depression, were analyzed. Depression severity and information on drug type and quantity were assessed at the beginning of the rehabilitation program and compared between women and men. Results: A significant difference between females and males was found in the frequency of prescribing bupropion (females: 3.61%, males: 12.89%; p=0.001) and mirtazapine (females: 5.15%, males: 13.40%; p=0.005). In terms of polypharmacy, the results showed that over 53% of the patients were taking two or more psychotropic substances as a long-term therapy and that 34% of them were taking three to five different substances. No sex-related differences were found concerning the number of psychotropic drugs taken by the patients. Conclusion: The higher frequency of prescriptions for bupropion and mirtazapine in men might be explained by the adverse drug reactions of the drugs (e.g., fewer sexually adverse drug reactions, weight gain) and a known interaction with oral contraception. It remains unclear whether these aspects are taken into consideration for each patient in terms of their special needs and conditions or whether it is a decision based on the patient's sex. Given a similar severity of depression, men and women are prescribed a similar number of psychotropic substances. However, the high number of psychotropic drugs prescribed on average should be noted. Well-trained healthcare professionals should focus on regularly assessing and optimizing treatment regimens.

References Powered by Scopus

A rating scale for depression

28499Citations
N/AReaders
Get full text

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report

4372Citations
N/AReaders
Get full text

Why is depression more common among women than among men?

995Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Antidepressant Effect of Magnolol on Depression-Like Behavior of CORT-Treated Mice

1Citations
N/AReaders
Get full text

Combination of low doses of mirtazapine plus venlafaxine produces antidepressant-like effects in rats, without affecting male or female sexual behavior

0Citations
N/AReaders
Get full text

Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Schwalsberger, K., Reininghaus, B., Reiter, A., Dalkner, N., Fleischmann, E., Fellendorf, F., … Reininghaus, E. Z. (2022). SEX-RELATED DIFFERENCES IN THE PHARMACOLOGICAL TREATMENT OF MAJOR DEPRESSION - ARE WOMEN AND MEN TREATED DIFFERENTLY? Psychiatria Danubina, 34(2), 219–228. https://doi.org/10.24869/psyd.2022.219

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Researcher 2

33%

Lecturer / Post doc 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

50%

Chemistry 2

25%

Pharmacology, Toxicology and Pharmaceut... 1

13%

Sports and Recreations 1

13%

Save time finding and organizing research with Mendeley

Sign up for free